MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Automated Differential Diagnosis of Parkinsonian Syndromes Using FDG-PET Metabolic Brain Network Analysis

T. Rus, P. Tomše, L. Jensterle, M. Grmek, Z. Pirtošek, D. Eidelberg, C. Tang, M. Trošt (Ljubljana, Slovenia)

Meeting: 2018 International Congress

Abstract Number: 1388

Keywords: Parkinsonism, Positron emission tomography(PET)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Neuroimaging And Neurophysiology

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To discriminate among parkinsonian patients using an automated network analysis of FDG-PET brain images.

Background: Clinical differentiating among parkinsonian syndromes: Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) may be challenging early in disease course. Disease specific metabolic brain patterns were identified for PD, MSA and PSP using Scaled Subprofile Modelling/Principal Component Analysis of FDG-PET images: PD related pattern (PDRP), MSA related pattern (MSARP) and PSP related pattern (PSPRP) (Poston KL, et al. 2010). Additionally, a probabilistic algorithm for the classification of individual patients with clinically uncertain parkinsonism was developed based on the expression of metabolic covariance patterns specific for PD, MSA and PSP (Tang CC, et al. 2010).

Methods: 137 patients with parkinsonism (disease duration 4.9±4 years) and uncertain clinical diagnosis underwent diagnostic FDG-PET. A network analysis was performed and the expressions of PDRP, MSARP and PSPRP were calculated using Topographic Profile Rating method. A probability for PD, MSA and PSP was calculated using the two stage logistic algorithm that distinguishes between PD and atypical parkinsonian syndrome (APS) in the first stage, and between MSA and PSP in the second. The calculated diagnosis was than compared to final clinical diagnosis made 21.4±13 months after imaging.

Results: Among 137 patients, 38 were excluded for alternative (not PD, MSA or PSP) diagnosis. Among 99 patients 66 were clinically diagnosed with PD, 17 with MSA and 16 with PSP. Automated algorithm diagnosed 57 patients with PD, 9 with MSA, 18 with PSP. Results were indeterminate in 15 cases. Discriminative measures of diagnostic accuracy for the first stage (PD vs atypical parkinsonian syndrome (APS)) and the second stage of diagnostic algorithm (MSA and PSP) are presented in table 1 (PPV – positive predictive value, NPV – negative predictive value). [table 1]

Conclusions: FDG-PET brain imaging with an automated differential diagnostic algorithm (Tang CC, et al. 2010) is a reliable tool for the improvement of early diagnosis in patients with uncertain parkinsonism.

References: 1. Poston KL, Eidelberg D. FDG PET in the Evaluation of Parkinson’s Disease. PET Clin. 2010;5(1):55-64. 2. Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol. 2010;9(2):149-58.

To cite this abstract in AMA style:

T. Rus, P. Tomše, L. Jensterle, M. Grmek, Z. Pirtošek, D. Eidelberg, C. Tang, M. Trošt. Automated Differential Diagnosis of Parkinsonian Syndromes Using FDG-PET Metabolic Brain Network Analysis [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/automated-differential-diagnosis-of-parkinsonian-syndromes-using-fdg-pet-metabolic-brain-network-analysis/. Accessed May 13, 2025.
  • Tweet
  • Email
  • Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/automated-differential-diagnosis-of-parkinsonian-syndromes-using-fdg-pet-metabolic-brain-network-analysis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley